SNCA and Parkinson disease: Together, these results led us to develop a hypothesis that PAK4 may be implicated in the aggregation of α-synuclein under pathophysiological conditions; decreased PAK4 activity in PD may contribute to α-synuclein aggregation, thus forming a vicious cycle (Fig. 1E).